Kirkland & Ellis is advising Patient Square, a dedicated health investment firm, on the $4.1 billion acquisition of Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor. A definitive agreement was announced December 11, 2024, and the transaction is expected to close in the fourth quarter of Patterson’s fiscal 2025, subject to the receipt of shareholder approval, regulatory approvals and customary closing conditions. Under the terms of the agreement, Patterson shareholders will receive $31.35 in cash per share, representing an approximately 49% premium to Patterson’s 30 calendar day volume-weighted average price ending December 4, 2024 (the last trading day prior to Patterson announcing the evaluation of strategic alternatives).
The Kirkland team included corporate lawyers Maggie Flores, Michael Weisser and Oliver Yee; debt finance lawyers John Ilardo, Jason Kanner and Joel Weinberger; capital markets lawyers Julia Danforth and Sophia Hudson; and tax lawyer Mark Schwed.
